Tax on Overseas Profit Fuels Loss for Eli Lilly

Eli Lilly has reported a surprise loss of $2.4 million in the fourth quarter, caused not by operational difficulties but by a big tax bite on billions of dollars it's bringing home from overseas and by a $36 million settlement-in-the-making with the Justice Department over improper product marketing. Without the $465 million U.S. tax bill, the set-aside for the settlement and other charges, the Indianapolis drugmaker would have posted a healthy 13 percent increase in profits, to $814 million, for the last quarter versus the same quarter a year ago.

IndyStar.com (http://www.indystar.com/articles/3/212613-1983-105.html)